Retatrutide 20mg

Retatrutide (LY3437943) is an investigational peptide that activates GLP-1, GIP and glucagon receptors. It is being studied in clinical research for effects on metabolic regulation, energy balance and body-weight-related endpoints. The triple-receptor profile distinguishes it from single- and dual-incretin receptor agonists.Research-use reference: Retatrutide remains an investigational compound. This description is not a therapeutic claim, dosing guide or representation of Australian approval.